The Competition Commission of India on Friday approved the proposed deal involving Sekhmet Pharmaventures and Optimus Drugs Pvt Ltd...
Lupin Limited announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application of Meclizine Hydrochloride Tablets USP...
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Prochlorperazine Maleate tablets, USP 5 mg and 10 mg...
With an estimated market value of USD 24.53 billion this year, the generic drugs market amounts for the major share of the Indian pharmaceutical industry. When compared to other countries in the global generic drug market, the Indian industry is...
The EU's drug watchdog said it aims to approve this autumn a Pfizer/BioNTech Covid vaccine adapted for two fast-spreading subvariants of the Omicron strain...
Unichem Laboratories Ltd said it has received an approval from the US health regulator to market its generic version of labetalol hydrochloride tablets used to treat high blood pressure...
Vedistry, from the house of Charak Pharma announced the launch of a nutritional supplement – Fortyfitt Woman Tablets. Keeping up with Charak’s commitment of delivering well-documented and scientifically researched formulations, FortyFitt Woman...
Drug major Cipla is betting big on digitisation and emerging segments like biosimilars and mRNA aided medications to drive its next phase of growth. The Mumbai-based drug maker is also bullish on maximising value opportunity in the complex generics i
JB Pharma, one of the fastest growing pharmaceutical companies in India, announced its financial results for the first quarter ended on June 30, 2022.
How the speed of single-use equipment adoption by Contract manufacturing organizations is outpacing the speed of biopharma innovators for small and mid-scale bioprocessing.
, CDSCO.jpg)
